Skip to content
Review Open access

Photothermal therapy triggering organelle stress and metabolic reprogramming to potentiate antitumor immunity

Jul 2026 · Frontiers in Immunology · Vol 17 · 0 citations · 280 references
Medicine

TL;DR

It is proposed that PTT interferes with tumor metabolism through organelle stress and synergizes with exogenous drugs to enhance metabolic perturbation, thereby eliciting a potent antitumor immune response.

Abstract

Metabolic reprogramming is a hallmark of malignant tumors, providing tumor cells with energy and promoting immune escape through changes in glucose, lipid, and amino acid metabolism. Photothermal therapy (PTT) not only eliminates tumor cells through localized hyperthermia but also disrupts metabolic networks. However, the mechanisms by which PTT-induced metabolic perturbation engages antitumor immunity remain a considerable challenge. This review proposes that PTT interferes with tumor metabolism through organelle stress and synergizes with exogenous drugs to enhance metabolic perturbation, thereby eliciting a potent antitumor immune response. We first detail how hyperthermia and ROS induced by PTT damage organelles, leading to organelle stress, including mitochondrial depolarization, endoplasmic reticulum (ER) proteotoxicity, cytosolic enzyme denaturation, and nucleolar stress. Critically, stressed organelles release immunogenic signals, activating the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway to trigger innate immune recognition, and regulating the functions of CD8+ T cells and macrophages through metabolites in the tumor microenvironment (TME). We also discuss how tumor cells activate adaptive responses, such as heat shock protein (HSP) upregulation and metabolic switching, to resist sublethal thermal stress, and evaluate synergistic strategies designed to amplify organelle stress and overcome thermotolerance. Finally, we focus on the latest advancements in overcoming tumor heterogeneity and advancing the clinical translation of targeted organelle PTT nanoplatforms. It is expected to elucidate the mechanism by which organelle stress in PTT causes metabolic perturbation, the tumor adaptive response, and its impact on tumor immunity, providing innovative ideas and references for the development of metabolic and tumor combined treatment strategies based on PTT.

Read PDF

Similar papers

Review Open access Aug 2026

Metabolic reprogramming and immune evasion interaction in the tumor microenvironment promote tumor progression

Emerging evidence demonstrates that tumor metabolic reprogramming not only supports tumor-cell proliferation but also promotes the establishment of an immunosuppressive tumor microenvironment (TME) by altering nutrient competition and metabolite accumulation. Therefore, metabolic reprogramming and immune evasion should...

Hai-Lun Wang, Han-Yuan Zhao, Xue-Lu Pu et al. · 0 citations
Review Open access Aug 2026

The Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment and the Mechanism of Immune Therapy Resistance

The article further explores therapeutic strategies targeting metabolic nodes such as lactate dehydrogenase A, CD73/CD39 - adenosine axis, to reverse immunosuppression and enhance the efficacy of ICIs, and looks forward to the future direction of using "metabolism-immunity" typing to guide individualized combination th...

Gan-Yu Yi · 0 citations
Review Open access Aug 2026

Metabolic Bottlenecks and Opportunities: Reshaping the Tumor Microenvironment for Cancer Immunotherapy

This review systematically elucidates the complex metabolic interplay between tumor cells and infiltrating T cells, highlighting two defining mechanisms driving immune evasion: the competitive sequestration of essential nutrients and the accumulation of immunosuppressive oncometabolites.

Jia-Ning Zhang, Zi-Mei Tang, Yiran Wang et al. · 0 citations
Review Open access Jul 2026

Mechanistic role of glycolytic pathways in the tumor microenvironment in driving chemoresistance

The role of glycolytic reprogramming is summarized in maintaining resistant tumor cell metabolic homeostasis, regulating the chemoresistant TME, and driving molecular mechanisms underlying chemotherapy resistance.

Zhongyi Tan, Lai Wen, He-Wen Guan et al. · 0 citations
Review Open access Aug 2026

The Cancer Cell Metabolic Reprogramming Remodels the Tumor Microenvironment: Molecular Mechanisms and Therapeutic Strategies

This review elucidates the regulatory mechanisms by which glucose, lipids, amino acid metabolism, nucleotide metabolism, oxidative phosphorylation, lactate, and hypoxia modulate the proliferation, differentiation, and function of anti‐tumor immune cells and immunosuppressive cells.

Guo-Qing Xiang, Zhi-Cheng Zhou, Xue Jiang et al. · 0 citations
Review Open access Jul 2026

Cholesterol metabolism reprogramming: shaping tumor immunity and immunotherapy

A deeper understanding of cholesterol and its metabolite dynamics within the tumor microenvironment, as well as their crosstalk with other signaling networks, will not only aid in optimizing current immunotherapeutic approaches but also provide a crucial conceptual foundation for developing novel combination strategies...

Jingzhi Meng, Yue Tan, Shang Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.